U.S. Pharmacist eNewsletter
February 2022

Model Shows Unrelated Vaccines Can Help Protect Against Severe COVID-19
While not nearly as effective as vaccines specifically targeting COVID-19, other routine vaccines can provide some cross-protection against multiple pathogens. A study using a model of a 2020 novel coronavirus outbreak found that unrelated, heterologous vaccine interventions could have reduced morbidity and mortality before the targeted vaccines were developed. Read more.


Pharmacist-Administered Shingles Vaccines Linked to Higher Completion Rates
Older Americans who start their shingles vaccine series at a pharmacy are more likely to get their second shot on time than those vaccinated in other settings. Despite that, competition rates remain too low overall, prompting researchers to try to determine why. Find out what factors make it more or less likely that the series is completed.


Study Finds Prevnar 20 Pneumococcal Vaccine Safe, Effective
More than half of all cases of invasive pneumococcal disease in adults aged 65 years or older are due to the 20 different serotypes in the recently approved 20-valent pneumococcal conjugate vaccine in adults aged 18 years and older. Now, a new study has confirmed the safety and effectiveness of the vaccine, marketed as Prevnar 20. Read more.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App
Advertisement Advertisement